Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis

Omae Kenji; Kondo Tsunenori; Kennoki Takafumi; Takagi Toshio; Iizuka Junpei; Kobayashi Hirohito; Hashimoto Yasunobu; Tanabe Kazunari

首页> 外文期刊>International journal of clinical oncology >Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis

【24h】

Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis

机译：索拉非尼治疗接受血液透析的日本转移性肾细胞癌患者的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Little information has been published on the use of tyrosine kinase inhibitors for treatment of patients undergoing hemodialysis (HD). We investigated the efficacy and safety of sorafenib for metastatic renal cell carcinoma (mRCC) patients undergoing HD.

机译：关于使用酪氨酸激酶抑制剂治疗接受血液透析（HD）的患者的信息很少。我们研究了索拉非尼在接受HD治疗的转移性肾细胞癌（mRCC）患者中的疗效和安全性。

著录项

来源
《International journal of clinical oncology》 |2016年第1期|共7页
作者
Omae Kenji; Kondo Tsunenori; Kennoki Takafumi; Takagi Toshio; Iizuka Junpei; Kobayashi Hirohito; Hashimoto Yasunobu; Tanabe Kazunari;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Renal cancer; End-stage renal disease; Prognosis; Survival; Biomarker;

机译：肾癌;终末期肾脏疾病;预后;生存期;生物标志物;

相似文献

外文文献
中文文献
专利

1. 索拉非尼与舒尼替尼一线治疗中国转移性肾细胞癌患者的疗效、安全性和生活质量的比较 [J] . Wen Cai, Wen Kong, Baijun Dong, 癌症（英文版） . 2018,第003期
2. Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis [J] . Omae Kenji, Kondo Tsunenori, Kennoki Takafumi, International journal of clinical oncology . 2016,第1期

机译：索拉非尼治疗接受血液透析的日本转移性肾细胞癌患者的疗效和安全性
3. 7147 Efficacy and safety of long-term use of sorafenib: final report of a phase II trial of sorafenib in Japanese patients with unresectable/metastatic renal cell carcinoma [J] . H.Akaza, S.Naito, T.Tsukamoto, European Journal of Cancer Supplements . 2009,第2期

机译：7147长期使用索拉非尼的疗效和安全性：索拉非尼在日本不可切除/转移性肾细胞癌患者中进行的II期临床试验的最终报告
4. Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: Subgroup analysis of Japanese patients from the global randomized phase 3 AXIS trial [J] . UedaT., UemuraH., TomitaY., Japanese journal of clinical oncology. . 2013,第6期

机译：阿昔替尼与索拉非尼在转移性肾细胞癌中的疗效和安全性：来自全球随机3期AXIS试验的日本患者的亚组分析
5. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
6. FACTORS AFFECTING SERUM LIPID LEVELS IN RENAL PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS TREATMENTS (DISEASE, DIET THERAPY). [D] . SALTOS, ETTA ANGEL. 1985

机译：正在进行维持性血液透析或连续性非循环性腹膜透析治疗（疾病，饮食疗法）的肾病患者血清脂水平的影响因素。
7. Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial [O] . Takeshi Ueda, Hirotsugu Uemura, Yoshihiko Tomita, -1

机译：阿西替尼与索拉非尼在转移性肾细胞癌中的疗效和安全性：从全球随机3期AXIS试验中日本患者的亚组分析
8. Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis [O] . Xinan Sheng, Zhihong Chi, Chuanliang Cui, 2016

机译：Sorafenib与Sunitinib的疗效和安全性作为转移性肾细胞癌患者的一线治疗：最大的单中心回顾性分析

Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis

摘要

著录项

相似文献

相关主题

期刊订阅